NaviCam Patency Capsule to Verify Gastrointestinal Patency
PATENCY
A Prospective, Single Center Clinical Trial Assessing the Efficacy and Safety of the NaviCam Patency Capsule to Verify Gastrointestinal Patency
1 other identifier
interventional
25
1 country
1
Brief Summary
Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2026
CompletedStudy Start
First participant enrolled
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 15, 2027
June 16, 2026
June 1, 2026
6 months
May 24, 2026
June 10, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Safety of patency capsule
The number of patients successfully passing the Patency Capsule within 30 hours compared to the number of patients where the Patency Capsule dissolves in patients with strictures.
30 hours
Efficacy of patency capsule
The percentage of patients that successfully pass the Patency capsule within 30 hours.
30 hours
Study Arms (1)
Single arm patency capsule evaluation
EXPERIMENTALParticipants will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm whether the capsule is still in the body.
Interventions
The NaviCam Patency Capsule is an accessory to the NaviCam capsule and is intended to verify adequate patency of the gastrointestinal tract prior to administration of the NaviCam capsule in patients with known or suspected strictures.
Eligibility Criteria
You may qualify if:
- Patients with suspected or known intestinal stricture (with medical history records, physical examination records, and imaging evidence within the last 6 months.
- Patients suffering from Crohn's Disease
- Patients with long-term use of non-steroidal anti-inflammatory drugs.
- Patients with abdominal symptoms related to intestinal stricture.
- Patients with chronic inflammatory diseases.
- Patients with difficulty with balloon-assisted endoscopy (BAE).
- Patients with a history of small bowel obstruction.
- Patients with a history of intestinal resection surgery.
You may not qualify if:
- Patients with esophageal obstruction or swallowing disorder diseases.
- Patients who are ineligible for surgery or refuse to undergo any abdominal surgery.
- Patients with known allergies or other contraindications or intolerance to the medications used in this study.
- Patients with pacemakers or other implanted electronic devices such as cochlear implants, magnetic metal drug infusion pumps, neurostimulators.
- Pregnant women
- Patients currently enrolled in another drug or device clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Digestive Health Services
Downers Grove, Illinois, 60515, United States
Related Publications (6)
Takeda K, Tashimo H, Miyakawa K, Shimada M, Ohshima N, Tamura A, Nagai H, Matsui H. Patency Capsule Aspiration. Intern Med. 2020 Apr 15;59(8):1071-1073. doi: 10.2169/internalmedicine.4012-19. Epub 2020 Jan 9.
PMID: 31915319BACKGROUNDOkoli A, Ammannagari N, Mazumder M, Nakkala K. When the dissolvable does not dissolve: an agile patency capsule mystery. Am J Gastroenterol. 2014 Apr;109(4):605-7. doi: 10.1038/ajg.2013.435. No abstract available.
PMID: 24698874BACKGROUNDMitselos IV, Katsanos K, Tsianos EV, Eliakim R, Christodoulou D. Clinical Use of Patency Capsule: A Comprehensive Review of the Literature. Inflamm Bowel Dis. 2018 Oct 12;24(11):2339-2347. doi: 10.1093/ibd/izy152.
PMID: 29718225BACKGROUNDSpada C, Shah SK, Riccioni ME, Spera G, Marchese M, Iacopini F, Familiari P, Costamagna G. Video capsule endoscopy in patients with known or suspected small bowel stricture previously tested with the dissolving patency capsule. J Clin Gastroenterol. 2007 Jul;41(6):576-82. doi: 10.1097/01.mcg.0000225633.14663.64.
PMID: 17577114BACKGROUNDHerrerias JM, Leighton JA, Costamagna G, Infantolino A, Eliakim R, Fischer D, Rubin DT, Manten HD, Scapa E, Morgan DR, Bergwerk AJ, Koslowsky B, Adler SN. Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc. 2008 May;67(6):902-9. doi: 10.1016/j.gie.2007.10.063. Epub 2008 Mar 19.
PMID: 18355824BACKGROUNDKopylov U, Nemeth A, Cebrian A, Wurm Johansson G, Thorlacius H, Fernandez-Urien Sainz I, Koulaouzidis A, Eliakim R, Toth E. Symptomatic retention of the patency capsule: a multicenter real life case series. Endosc Int Open. 2016 Sep;4(9):E964-9. doi: 10.1055/s-0042-112588. Epub 2016 Aug 8.
PMID: 27652302BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rockford G Yapp, MD
Digestive Health Services
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2026
First Posted
June 16, 2026
Study Start
June 15, 2026
Primary Completion (Estimated)
December 15, 2026
Study Completion (Estimated)
March 15, 2027
Last Updated
June 16, 2026
Record last verified: 2026-06